Position in GMAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$46,404,631
+$28,231,438 QoQ
Shares Held
1,689,284
+149.4% QoQ
Ownership
0.275%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#14
of 292 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. GMAB ranks #18 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in GMAB
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,404,631 | 1,689,284 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,173,193 | 677,346 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,215,214 | 39,455 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,176,434 | 111,156 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,942,767 | 236,836 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,644,227 | 313,545 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,877,962 | 114,523 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,117,263 | 237,956 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,186,573 | 257,116 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $4,585,346 | 130,007 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $8,721,356 | 229,449 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $10,323,697 | 273,403 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,489,252 | 389,081 | Shares | Sole | 2023-02-14 | |
| 2022-03-31 | $839,303 | 23,198 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $1,554,075 | 39,284 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $642,433 | 14,701 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $951,951 | 23,315 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $1,235,372 | 30,383 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $656,197 | 17,924 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||